AKT1 and breast cancer: PAC administration inhibited the growth of subcutaneously implanted MDA-MB-231 breast cancer cells in a nude mice model and was associated with downregulation of AKT and ERK1/2, up-regulated E-cadherin, while it down-regulated N-cadherin, vimentin, and TWIST1 [195,196].